Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care
Oct 3, 2026, 05:52

Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care

Kemal Karaagac, Cardiologist at Cihangir Hospital, shared a post on X about a recent article by Eva Kempers et al., published in Heart, adding:

“VKAs remain essential when DOACs are unsuitable or their benefit is uncertain, including mechanical valves, AF with moderate-to-severe mitral stenosis, thrombi, and some frail older patients. Despite DOAC advances, VKA therapy remains vital in selected patients.”

Title: Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice

Authors: Eva K. Kempers, Melanie Jacqueline J. Acampo-de Jong, Hugo ten Cate, Raffaele De Caterina, and Marieke J. H. A. Kruip

Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care

 

Stay updated on all scientific advances with Hemostasis Today.